CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in ELAN — Elanco Animal Health Inc

CIK 884546 SAN FRANCISCO, CA

Back to ELAN Full portfolio

Position in ELAN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$85,617,950

+$5,491,276 QoQ

Shares Held

3,577,850

+1.0% QoQ

Ownership

0.716%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 99.99435415123608.ToString("F0")% Shared 0.ToString("F0")% None 0.005645848763922467.ToString("F0")%

Common Shares in ELAN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,628,257,886 across 43 Drug Manufacturers - Specialty & Generic names. ELAN ranks #5 (5.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	3,717,247	$439,415,767
2	VTRS	Viatris Inc	13,674,306	$184,739,874
3	UTHR	UNITED THERAPEUTICS Corp	300,481	$178,179,223
4	NBIX	Neurocrine Biosciences Inc	902,788	$118,933,291
5	ELAN	Elanco Animal Health Inc This page	3,577,850	$85,617,950
6	ALKS	Alkermes plc.	2,236,756	$79,091,692
7	TEVA	Teva Pharmaceutical Industries Ltd	2,087,679	$62,880,891
8	LNTH	Lantheus Holdings, Inc.	657,413	$49,864,776

All Filings in ELAN

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$85,617,950	3,577,850	+1.0%	Shares	Sole	2026-05-15
2025-12-31	$80,126,674	3,540,728	-9.7%	Shares	Sole	2026-02-13
2025-09-30	$78,931,459	3,919,139	-8.4%	Shares	Sole	2025-11-10
2025-06-30	$61,099,064	4,278,646	-4.3%	Shares	Sole	2025-08-12
2025-03-31	$46,951,779	4,471,598	-4.6%	Shares	Sole	2025-09-15
2024-12-31	$56,766,957	4,687,610	+3.6%	Shares	Sole	2025-02-06
2024-09-30	$66,466,609	4,524,616	-3.4%	Shares	Sole	2024-11-12
2024-06-30	$67,605,401	4,685,059	-0.5%	Shares	Sole	2024-08-12
2024-03-31	$76,657,277	4,708,678	-0.5%	Shares	Sole	2024-05-09
2023-12-31	$70,519,792	4,732,872	+0.5%	Shares	Sole	2024-02-06
2023-09-30	$52,953,663	4,711,180	+20.9%	Shares	Sole	2023-11-08
2023-06-30	$39,198,910	3,896,512	+12.0%	Shares	Sole	2023-08-10
2023-03-31	$32,690,323	3,477,694	+2.5%	Shares	Sole	2023-05-12
2022-12-31	$41,476,341	3,394,136	+8.5%	Shares	Sole	2023-02-13
2022-09-30	$38,830,989	3,129,008	-2.0%	Shares	Sole	2022-11-14
2022-06-30	$62,655,995	3,191,849	+7.8%	Shares	Sole	2022-08-15
2022-03-31	$77,263,604	2,961,426	+6.4%	Shares	Sole	2022-05-13
2021-12-31	$78,989,032	2,783,264	+2.9%	Shares	Sole	2022-02-11
2021-09-30	$86,257,092	2,704,832	+3.5%	Shares	Sole	2021-11-16
2021-06-30	$90,635,326	2,612,722	+1.5%	Shares	Sole	2021-08-16
2021-03-31	$75,833,543	2,574,993	+0.8%	Shares	Sole	2021-05-17
2020-12-31	$78,341,638	2,554,341	+42.7%	Shares	Sole	2021-02-16
2020-09-30	$49,979,254	1,789,447	+42.0%	Shares	Sole	2020-11-13
2020-06-30	$27,025,584	1,259,934	+13.0%	Shares	Sole	2020-08-20
2020-03-31	$24,962,499	1,114,895	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.